Regulate

Intu Diagnostics develops rapid and instrument-free solutions for infectious disease diagnostics, aiming for affordability and global accessibility. The company is committed to implementing a sustainable and socially responsible business model to contribute to better global health through its technology. The product portfolio includes solutions like PCR-TO-GO, designed to bring doctor's office-level diagnostics to the patient's door.

Maple Aviation is a medical logistics startup that specializes in building and operating autonomous drone networks. Their fleet is designed to quickly transport urgent medication, blood vials, and laboratory samples directly between healthcare facilities and hospital windows. By moving critical healthcare supplies through the air, the company bypasses road traffic to significantly speed up diagnostic turnaround times.

Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly way. The state-of-the-art software supports all staff in their daily work and additionally enables the development and use of innovations such as artificial intelligence, Big Data, telemedicine, patient applications and wearables to fundamentally improve patient care and research.

InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA.

XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.

Wellster is the go-to solution for everyday consumer health. It builds digital clinics along the lifecycle of next gen. health consumers.

Berlin Heals Holding is a developer of implantable medical device for the cure of heart failure.

Recare is reevaluating the process of discharge management by utilizing digital tools to improve communication between hospitals and care providers. The focus is on their cloud-based platform, which allows for immediate coordination of resources and secure communication in accordance with privacy regulations. This allows for more time to be spent on patient care, which is the most crucial aspect of the healthcare process.

Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.

Arab Therapy functions as a startup that focuses on mental health.

Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a portfolio of digital therapeutics medical software products that cover the entirety of behavioural treatment needs of cancer patients. Our clinically validated platform is set to be prescribed by doctors and therapists in Germany, and it will be reimbursed by the local healthcare system in 2022. We aim to become #1 global digital therapeutics solution for oncology and we have a pathway to get there. Prosoma’s “Software as a Medical Device” platform is a set of stand-alone apps tailored to the different stages of the patient’s journey, which includes: symptoms and treatment support, psycho-social support, and behavioural support. All of these pathways are clinically validated and accessible at any time and anywhere the patient needs it. Our medical self-care applications are designed to deliver therapeutic methods personalised to each patient based on their diagnosis and outcomes. It is the most comprehensive toolset to make patient’s life better. Prosoma is developed by medical experts and patients. We partner with the most renowned organisations for the clinical trials, as well as, large scale commercial partners in the USA and Germany. We are a part of various acceleration programmes such as: Accelerate Cambridge, Incredibles, and the HealthHub at the University of California. Prosoma is being developed and built to meet EU Medical Device Regulations: ISO 13485, ISO 62304, and ISO 27001. We are proud to be funded by a VC fund and Business Angels who support our vision and strategy. In 2020, Prosoma received an NCBiR grant for developing a COVID-19 centred product.

Mallia Innovations specializes in creating evidence-based hair regeneration solutions that target specific areas, with an emphasis on immunological research, therapeutic effectiveness, and noticeable outcomes.